Author: healthylife7

This is a paid press release. Contact the press release distributor directly with any inquiries.

A nonpartisan commission of leaders in health, policy, medicine, and business released a roadmap today to empower local health departments and elected officials to shore up public health in their communities

A study suggests that eating 1 avocado per day can reduce low-density lipoprotein (LDL) levels, a marker of cardiovascular disease risk,in adults with abdominal obesity

“Nature is simple, uncomplicated beauty that is multi-beneficial, purposeful, and filled with glorious scents. It is the inspiration behind every product and formulation we create. Our multi-beneficial, multi-purpose products allow you to discover how nat

LifeArc and Rare Disease Research UK (RDR UK) have announced the launch of Raremap, a new online directory designed to improve collaboration across the UK’s rare disease sector by helping organisations identify expertise, build partnerships and navigate the complex research landscape

The GLP-1 conversation keeps expanding. We’ve covered Ozempic face, hair loss, muscle loss and what happens after you stop the medication. Now, a new NBER working paper by economist Rebecca Diamond, titled “GLP-1-Induced Weight Loss and the Female Obesity Penalty,” adds an uncomfortable new layer: GLP-1–related weight loss may also be linked to who lands…

An Austin-based Krav Maga gym was destroyed in a fireWednesday morning, forcing it to suspend classes indefinitely as its owner works to rebuild

Ala. (WALA) – Most Americans know eating healthy is important. The problem is that for many families, it’s becoming harder to make that happen

A group of 26 Meta employees has sued the company, claiming it used artificial intelligence systems to select people for layoffs, disproportionately targeting those on medical, parental or family leave

Setmelanotide, a melanocortin-4 receptor agonist, significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The New England Journal of Medicine. Although focused primarily on patients with craniopharyngioma, this study addresses a clinically important survivorship issue: the management of…